Braynelle’s Story: Living with Dravet Syndrome
December 3, 2023
Braynelle and Brandon have been managing their son Kai’s diagnosis of Dravet Syndrome since he was four months old. After starting medication distributed by Anovo, the frequency of Kai’s epileptic seizures has reduced dramatically, giving him the quality of life he deserves. In this video, Braynelle describes how the reliability of Anovo was able to return her peace of mind after years of uncertainty when it comes to the logistic challenges of managing her son’s rare disease.
“Anovo is always on my side.”
Related Posts
Investing in Training to Elevate Patient Care
At Anovo, we believe that exceptional patient support starts with a well-trained, knowledgeable team. As we continue to grow, we’ve…
April 1, 2025
Case Study: Transitioning Egetis Therapeutics’ Expanded Access Program to Anovo
As Egetis prepared for its first launch, it made the strategic decision to partner for the management of its Expanded…
March 28, 2025
How Anovo Builds Dedicated Teams to Support Your Rare Disease Therapy
At Anovo, we understand that complex rare disease therapies require high-touch service that large payer- and Pharmacy Benefit Manager-owned Specialty…
January 24, 2025
